外资药企进入中国市场的并购策略及并购对国内药-中国政法大学MBA.docVIP

中国政法大学硕士学位论文 外资药企进入中国市场的并购策略及并购对国内药企的影响 STYLEREF 样式1 \l \* MERGEFORMAT 参考文献 PAGE 38 PAGE 37 论文编号： 医药企业战略并购的策略及建议 ——以赛诺菲并购太阳石案为例 赵子涓 中国政法大学研究生院 二○一五年三月 医药企业战略并购的策略及建议 ——以赛诺菲并购太阳石案为例 摘 要 随着医疗改革的不断深入，我国的医药企业无论在产品开发、品牌塑造还是生产能力、营销手段等竞争力指标都有显著提升，已经培育了一批较有影响力和知名度的本土企业。但由于国内市场广阔，药品销售利润可观且国内药品的技术壁垒还相对较低，越来越多的国际药业巨头试水中国市场，因此从2000年以来，外资药企并购中资药业的案例频发。 本研究通过国际第三大制药企业并购国内知名民企药业的目的、策略和具体操作方法入手，对并购活动的效果进行分析和评价，并对未来中国药企走向世界提供一些建议和借鉴。 本研究从经济学管理学相结合的研究视角，采用案例研究与定性研究相结合的方法，对并购理论在医药行业的具体应用进行尝试，同时也从实务操作的角度，强调重视清单、第三方介入和并购整合的重要作用。 本文的主要结构为，前两章阐明并购的理论综述，文章的研究背景、目的、意义等；第三章就国内外医药企业并购与重组现实状况加以分析；第四章以赛诺菲并购太阳石为例，通过定性定量相结合的方法，阐明并购的操作过程及成功关键因素；第五章从案例出发，对并购后新企业的机遇与挑战加以分析；最后一章从市场、技术、政策三方面分别提出了有助于战略并购的策略建议。 关键词：医药企业，外资并购，战略并购，清单，并购策略 THE STRATEGY AND THE SUGGESTION OF THE PHARMACEUTICAL ENTERPRISE STATEGIC MA——Sanofic companies merger Sun Stones Abstract With the deepening of the medical reform, Chinas pharmaceutical enterprises in product development, branding and production capacity, marketing competitiveness index were significantly increased, there is a number of influential and famous domestic enterprises. Profitable but due to a vast market in China, drugs and domestic pharmaceutical technical barriers still relatively low, more and more international pharmaceutical giant to the Chinese market, therefore, since 2000, foreign drug companies mergers and acquisitions frequent cases of Chinese pharmaceutical industry. This study through the third-largest pharmaceutical enterprise mergers and acquisitions of domestic well-known corporation pharmaceutical purposes, strategies, and specific operation method, this paper analyzes the effect of mergers and acquisitions and evaluation, and for the future Chinese drug companies to provide some Suggestions and reference towards the world. This study from the perspective of economics management with the combination of research, adopt the method of case study combined with qualitative research, the concrete application of theory of mergers and acqui